Effect of chamomile infusion on blood glucose, lipid profile and serum kidney functions

Not Applicable

• Conditions: type 2 diabetes.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT2014120918329N2
• Lead Sponsor: Vice chancellor for research of Shahid Sadoughi University of medical sciences, Yazd, Iran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

patients with type 2 diabetic aged over the 30 years; not having a history of gastrointestinal, renal, hepatic and heart disorders or allergic reactions to chamomile plant; not being under insulin therapy.

Exclusion criteria: consuming less than 30 % of the packed chamomile; changing the dose of medicines within the last 6 months or during the intervention; following a specific diet and changing their physical activity.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood glucose. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;2hour postprandial blood glucose. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Total cholesterol. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Triglyceride. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Low density lipoprotein. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;High density lipoprotein. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.

Secondary Outcome Measures

Name	Time	Method
Creatinine. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Urea. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.